Novartis AG - ADR XNYS: NVS

Mid-range Performer

Download real time

126.55 -1.50 (-1.17%)

New 52W High in past week

985.0K

XNYS Volume

XNYS 10 Sep, 2025 5:30 PM (EDT)

Acquisition

Novartis to acquire Tourmaline Bio for $1.4 billion to expand its cardiovascular pipeline See details

Novartis AG - ADR quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents